<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
    <title>Briefs</title>
    <description>
      <![CDATA[]]>
    </description>
    <link>https://www.bioworld.com/rss</link>
    <language>en-us</language>
    <item>
      <title>Biopharma money raised: Jan. 1-April 9, 2026</title>
      <description>
        <![CDATA[Year-to-date money raised in public, private and other financings of biopharma companies.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730324</guid>
      <pubDate>Fri, 10 Apr 2026 13:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730324-biopharma-money-raised-jan-1-april-9-2026</link>
    </item>
    <item>
      <title>Money raised by biopharma</title>
      <description>
        <![CDATA[Total raised in public, private and other financings of biopharma companies, comparing 2019-2026.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730323</guid>
      <pubDate>Fri, 10 Apr 2026 13:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730323-money-raised-by-biopharma</link>
    </item>
    <item>
      <title>Regulatory actions for April 10, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Duality, Glenmark, Macrogenics, Modular Medical, Novo Nordisk.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730233</guid>
      <pubDate>Fri, 10 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730233-regulatory-actions-for-april-10-2026</link>
    </item>
    <item>
      <title>Other news to note for April 10, 2026</title>
      <description>
        <![CDATA[Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: 23andMe, Assertio, Ataraxis, Biomérieux, BMS, Cartherics, Cartography, Catalent, Cosette, Daiichi, Deck Bio, Eli Lilly, Garda, Gilead, GE, Imagene, Kymera, Medical Microinstruments, Myndtec, Nxera, Oxford, Paindrainer.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730232</guid>
      <pubDate>Fri, 10 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730232-other-news-to-note-for-april-10-2026</link>
    </item>
    <item>
      <title>In the clinic for April 10, 2026</title>
      <description>
        <![CDATA[Clinical updates for biopharma and med tech, including data readouts and publications: Leads Biolabs, Smith+Nephew, Zentalis.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730231</guid>
      <pubDate>Fri, 10 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730231-in-the-clinic-for-april-10-2026</link>
    </item>
    <item>
      <title>Financings for April 10, 2026</title>
      <description>
        <![CDATA[Biopharma and med-tech companies raising money in public or private financings, including: Annovis, Avalyn, Boehringer, Click, Forte.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730230</guid>
      <pubDate>Fri, 10 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730230-financings-for-april-10-2026</link>
    </item>
    <item>
      <title>Appointments and advancements for April 10, 2026</title>
      <description>
        <![CDATA[New hires and promotions in the biopharma and med-tech industries, including: Byondis, Carvolix, Curonix, Egetis, Idorsia, Medicenna, Orthofix, OS, Plus, Precision Neuroscience, Pulse, Rani, Sonablate, Telix, Zymeworks.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730229</guid>
      <pubDate>Fri, 10 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730229-appointments-and-advancements-for-april-10-2026</link>
    </item>
    <item>
      <title>Today's news in brief</title>
      <description>
        <![CDATA[BioWorld briefs for April 10, 2026.]]>
      </description>
      <guid>http://www.bioworld.com/articles/432891</guid>
      <pubDate>Fri, 10 Apr 2026 10:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/432891-todays-news-in-brief</link>
    </item>
    <item>
      <title>Regulatory actions for April 9, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Anumana, Bausch + Lomb, Becton Dickinson, Cortec, Endospan, Etiometry, GSK, Plus, United, Waters.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730219</guid>
      <pubDate>Thu, 09 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730219-regulatory-actions-for-april-9-2026</link>
    </item>
    <item>
      <title>Other news to note for April 9, 2026</title>
      <description>
        <![CDATA[Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Astellas, Bioporto, Dyno, Janel.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730218</guid>
      <pubDate>Thu, 09 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730218-other-news-to-note-for-april-9-2026</link>
    </item>
    <item>
      <title>In the clinic for April 9, 2026</title>
      <description>
        <![CDATA[Clinical updates for biopharma and med tech, including data readouts and publications: Ascendis, Ataibeckley, Insmed, Radiopharm.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730217</guid>
      <pubDate>Thu, 09 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730217-in-the-clinic-for-april-9-2026</link>
    </item>
    <item>
      <title>Financings for April 9, 2026</title>
      <description>
        <![CDATA[Biopharma and med-tech companies raising money in public or private financings, including: Circio, Incyclix, Oncomatryx, Realta.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730216</guid>
      <pubDate>Thu, 09 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730216-financings-for-april-9-2026</link>
    </item>
    <item>
      <title>Appointments and advancements for April 9, 2026</title>
      <description>
        <![CDATA[New hires and promotions in the biopharma and med-tech industries, including: Aravax, Impedimed, Latigo, Orano Med, Remedy, Spectral AI, Stealth, Stoke, Supira.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730215</guid>
      <pubDate>Thu, 09 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730215-appointments-and-advancements-for-april-9-2026</link>
    </item>
    <item>
      <title>Regulatory actions for April 8, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Artivion, Ascendis, Baylis, Climb Bio, Invera, Neuropacs, Nextcure, Nuvalent, NX Development, Organogenesis, Outlook, Royal Biologics, Savara.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730159</guid>
      <pubDate>Wed, 08 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730159-regulatory-actions-for-april-8-2026</link>
    </item>
    <item>
      <title>Other news to note for April 8, 2026</title>
      <description>
        <![CDATA[<p>Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: AC Immune, Alloy, Amgen, Biocon, Biogen, Caryhealth, Cipher, Cellution, Cipher, Eli Lilly, Engene, Gatc, Halozyme, Lunai, Medstar, Merck, Pathai, Renovare, Vertex, Terns.</p>]]>
      </description>
      <guid>http://www.bioworld.com/articles/730158</guid>
      <pubDate>Wed, 08 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730158-other-news-to-note-for-april-8-2026</link>
    </item>
    <item>
      <title>In the clinic for April 8, 2026</title>
      <description>
        <![CDATA[Clinical updates for biopharma and med tech, including data readouts and publications: Akeso, Evaxion,Merakris, Neurotherapia, Sanofi.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730157</guid>
      <pubDate>Wed, 08 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730157-in-the-clinic-for-april-8-2026</link>
    </item>
    <item>
      <title>Financings for April 8, 2026</title>
      <description>
        <![CDATA[Biopharma and med-tech companies raising money in public or private financings, including: Celldex, Ensysce, Kiora, Marvel, Polyrizon, Route 92, Transcode, Vivos.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730156</guid>
      <pubDate>Wed, 08 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730156-financings-for-april-8-2026</link>
    </item>
    <item>
      <title>Appointments and advancements for April 8, 2026</title>
      <description>
        <![CDATA[New hires and promotions in the biopharma and med-tech industries, including: Abeona, Avicanna, Biovica, Cytovale, Helio Genomics, Jupiter, Lytix, Palvella, Pharmability, Tenpoint, Trisalus, Tuhura, Zimmer.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730155</guid>
      <pubDate>Wed, 08 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730155-appointments-and-advancements-for-april-8-2026</link>
    </item>
    <item>
      <title>Regulatory actions for April 7, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Allevion, Regeneron, Stereotaxis.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730145</guid>
      <pubDate>Tue, 07 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730145-regulatory-actions-for-april-7-2026</link>
    </item>
    <item>
      <title>Other news to note for April 7, 2026</title>
      <description>
        <![CDATA[Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Bioinsights, Denali, Immunitybio, Inspira, Nano Dimension, NEC Bio, Profusa, Takeda, Transgene.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730144</guid>
      <pubDate>Tue, 07 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730144-other-news-to-note-for-april-7-2026</link>
    </item>
    <item>
      <title>In the clinic for April 7, 2026</title>
      <description>
        <![CDATA[Clinical updates for biopharma and med tech, including data readouts and publications: Alar, Amgen, Praxis, Vedanta.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730143</guid>
      <pubDate>Tue, 07 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730143-in-the-clinic-for-april-7-2026</link>
    </item>
    <item>
      <title>Financings for April 7, 2026</title>
      <description>
        <![CDATA[Biopharma and med-tech companies raising money in public or private financings, including: Acurion, Beacon, Innocan, Opus, OS Therapies, Sharp, Syneron.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730142</guid>
      <pubDate>Tue, 07 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730142-financings-for-april-7-2026</link>
    </item>
    <item>
      <title>Appointments and advancements for April 7, 2026</title>
      <description>
        <![CDATA[New hires and promotions in the biopharma and med-tech industries, including: Avalyn, Biocryst.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730141</guid>
      <pubDate>Tue, 07 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730141-appointments-and-advancements-for-april-7-2026</link>
    </item>
    <item>
      <title>Regulatory actions for April 7, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: 4DMedical, Abbisko, Eisai, GSK, Merck, SS Innovations.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730114</guid>
      <pubDate>Tue, 07 Apr 2026 08:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730114-regulatory-actions-for-april-7-2026</link>
    </item>
    <item>
      <title>Other news to note for April 7, 2026</title>
      <description>
        <![CDATA[Biopharma and med-tech happenings in Asia-Pacific, including deals and partnerships, and other news in brief: Adagene, Amgen, AP Biosciences, Aurinia, Axsome, Biocytogen, Daiichi Sankyo, Enodia, Everest Medicines, Frontier Medicines, Incyte, Kezar, LG Chem, Lupin, Nuvation, Shionogi, Taisho, Takeda, Tanabe, Tasly, Visufarma, Zai Lab.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730113</guid>
      <pubDate>Tue, 07 Apr 2026 08:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730113-other-news-to-note-for-april-7-2026</link>
    </item>
    <item>
      <title>In the clinic for April 7, 2026</title>
      <description>
        <![CDATA[Clinical updates for biopharma and med tech in Asia-Pacific, including data readouts and publications: Adagene, Braveheart, Connect, Gan & Lee, Hengrui, Simcere, Takeda.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730112</guid>
      <pubDate>Tue, 07 Apr 2026 08:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730112-in-the-clinic-for-april-7-2026</link>
    </item>
    <item>
      <title>Financings for April 7, 2026</title>
      <description>
        <![CDATA[Biopharma and med-tech companies in Asia-Pacific raising money in public or private financings: 4DMedical, Adagene, Hangzhou Diagens, Stairmed.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730111</guid>
      <pubDate>Tue, 07 Apr 2026 08:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730111-financings-for-april-7-2026</link>
    </item>
    <item>
      <title>Appointments and advancements for April 7, 2026</title>
      <description>
        <![CDATA[New hires and promotions in the biopharma and med-tech industries in Asia-Pacific, including: Telix, Transcenta.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730110</guid>
      <pubDate>Tue, 07 Apr 2026 08:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730110-appointments-and-advancements-for-april-7-2026</link>
    </item>
    <item>
      <title>News in brief</title>
      <description>
        <![CDATA[BioWorld Asia briefs for April 7, 2026]]>
      </description>
      <guid>http://www.bioworld.com/articles/435994</guid>
      <pubDate>Tue, 07 Apr 2026 01:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/435994-news-in-brief</link>
    </item>
    <item>
      <title>Regulatory actions for April 6, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Cocrystal, Context, Fore, Eli Lilly, Merck, Ultragenyx, Zeto.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730131</guid>
      <pubDate>Mon, 06 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730131-regulatory-actions-for-april-6-2026</link>
    </item>
  </channel>
</rss>
